Breast Density

Breast density, or fibroglandular density, is found through breast imaging and varies based on the amount of fat to the amount of connective tissue. About 50 percent of women have what is referred to as dense breasts, where the tissue appears white on mammograms and can hide cancers, which also appear white. Women with very dense breasts may need to undergo supplemental imaging that can see through dense breast tissue, such as breast ultrasound, breast MRI or nuclear imaging. Many U.S. states now have legislation requiring radiologists to inform patients if they have dense breasts. Some states also now require insurance companies to cover supplemental imaging in these patients. Breast density is graded into 4 classes, or BI-RAD scores, to explain the level of density in the radiology report.

Deal further expands Hologic’s portfolio of world-class breast health solutions addressing the full continuum of care

News | Breast Imaging | January 04, 2021

Hologic to Acquire SOMATEX, Leader in Biopsy Site Markers and Localization Technologies

January 4, 2021 — Hologic, Inc. announced it has completed the acquisition of SOMATEX Medical Technologies GmbH, a...

Smart Breast Corporation (SmartBreast), a privately held company focused on breast cancer screening and detection, announced today that it has acquired certain molecular breast imaging (MBI) assets from Dilon Technologies, Inc. (Dilon) for an undisclosed amount.

News | Breast Imaging | January 04, 2021

SmartBreast Acquires Molecular Breast Imaging Assets from Dilon Technologies

January 4, 2021 — Smart Breast Corporation (SmartBreast), a privately held company focused on breast cancer screening...

Volpara Health announced two new research studies using AI-powered software to score breast density objectively and consistently to evaluate its impact in mammography and breast cancer risk assessment.

News | Breast Density | December 30, 2020

Volpara Health's AI-powered Breast Density Software Central to New Breast Density Studies

December 30, 2020 — Volpara Health announced two new research studies using AI-powered software to score breast density...

The American College of Radiology (ACR), Society of Breast Imaging (SBI), patient advocates and others secured an extension of the moratorium on harmful 2009 and 2016 United States Preventive Services Task Force (USPSTF) Breast Cancer Screening Guidelines from Dec. 31, 2021 to Dec. 31, 2022.

Getty Images

News | Breast Imaging | December 29, 2020

Mammography Protections in Year-end Legislation Help Efforts to Address Breast Cancer Care Disparities

December 29, 2020 — The American College of Radiology (ACR), Society of Breast Imaging (SBI), patient advocates and...

According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase in mortality from non-coronavirus-related diseases. This includes breast cancer, and researchers believe fear of contracting the virus compels patients to stay home instead of completing their post-lumpectomy radiotherapy regimens.

Image courtesy of Zeiss

News | Radiation Therapy | December 21, 2020

Single-Dose Radiation Therapy Can Counteract Serious Breast Cancer Treatment Compliance Issues During Pandemic

December 21, 2020 — According to recent studies, an increase in the COVID-19 positivity rate correlates to an increase...

The global breast imaging technologies market was valued at USD 3.54 billion in 2019 and is projected to surpass USD 7.43 billion by 2030, expanding at a CAGR of 6.90% during the forecast period from 2020 to 2030.

Getty Images

News | Breast Imaging | December 21, 2020

Global Breast Imaging Technologies Market Opportunity Analysis and Industry Forecast 2020-2030

December 21, 2020 — The "Breast Imaging Technologies Market by Technology - Global Opportunity Analysis and Industry...

David Kleinman, Chief Information Officer at US Radiology

David Kleinman, US Radiology

News | Breast Imaging | December 18, 2020

US Radiology Selects Volpara Health to Drive Quality Breast Imaging Across the Network

December 18, 2020 — US Radiology Specialists, one of the premier physician-owned radiology operators in the country, ...

New software-based application helps clinicians visualize breast anatomy and provides detailed characterization of lesions

News | Breast Imaging | December 17, 2020

Hologic Adds 3-D Breast Ultrasound Imaging to SuperSonic MACH 40 System

December 17, 2020 — Hologic, Inc. announced that 3-D ultrasound imaging is now available on the SuperSonic MACH 40...

Among patients with breast cancer treated with radiotherapy, under-recognition of symptoms was common in reports of pain, pruritus, edema and fatigue, with younger patients and Black patients having significantly increased odds of symptom under-recognition, according to data presented at the 2020 San Antonio Breast Cancer Symposium

Getty Images

News | Women's Health | December 14, 2020

Under-recognition of Symptoms May Be Common in Breast Cancer Patients Receiving Radiation

December 14, 2020 — Among patients with breast cancer treated with radiotherapy, under-recognition of symptoms was...

Images show symptomatic false-negative cancer in a 73-year-old black woman who presented with a palpable abnormality 64 days after negative screening mammography. (a) Negative screening left digital breast tomosynthesis (DBT) mammogram. (b) Diagnostic DBT mammogram shows a new palpable mass (arrow). (c) Spot-compression DBT mammogram enables confirmation of mass (arrow). (d) Ultrasound (US) image shows hypoechoic mass with angular margins. Subsequent US-guided biopsy revealed estrogen receptor- and progeste

Images show symptomatic false-negative cancer in a 73-year-old black woman who presented with a palpable abnormality 64 days after negative screening mammography. (a) Negative screening left digital breast tomosynthesis (DBT) mammogram. (b) Diagnostic DBT mammogram shows a new palpable mass (arrow). (c) Spot-compression DBT mammogram enables confirmation of mass (arrow). (d) Ultrasound (US) image shows hypoechoic mass with angular margins. Subsequent US-guided biopsy revealed estrogen receptor- and progesterone receptor-positive and human epidermal growth factor receptor 2-negative invasive ductal carcinoma. Image courtesy of Radiological Society of North America

News | Breast Imaging | December 07, 2020

Digital Breast Tomosynthesis Improves Invasive Cancer Detection

December 7, 2020 — Breast cancer screening with digital breast tomosynthesis (DBT) offers significant advantages over...

Guidance for mammography facilities, state MQSA contract partners, FDA-approved MQSA accreditation bodies and Food and Drug Administration staff

Getty Images

News | Mammography | December 04, 2020

FDA Issues Guidance on Enforcement Policy for the Quality Standards of the Mammography Quality Standards Act

December 4, 2020 — Today, the U.S. Food and Drug Administration (FDA) issued an immediately in effect guidance, ...

Studies show new deep-learning algorithm helps radiologists detect breast cancers in their early stages when used with the Genius 3D Mammography exam

News | Breast Imaging | December 02, 2020

Hologic Receives FDA Clearance for Genius AI Detection

December 2, 2020 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s...

Lunit’s algorithm showed the best performance compared to other commercialized AI algorithms, ultimately reducing the workload of radiologists to classify mammography screenings

News | Artificial Intelligence | December 02, 2020

Recent Studies Reveal High Performance of Lunit AI in Breast Cancer Detection

December 2, 2020 — Recent studies have shown that Lunit’s AI solution is as accurate as average radiologists when it...

ProFound AI for DBT offers superior clinical performance when compared to other commercially available breast AI systems

News | Breast Imaging | November 24, 2020

iCAD Reports Over 1,000 Licenses Sold as Part of ProFound AI Sales

November 24, 2020 — iCAD reported that over 1,000 licenses have been sold as part of ProFound AI sales since the...

Densitas Inc., a global provider of A.I. technologies for digital mammography and breast screening, announced its partnership with Mammography Educators to offer the first artificial intelligence powered telehealth technologist training platform to support business continuity in mammography facilities.

News | Mammography | November 20, 2020

Densitas Partners with Mammography Educators to Launch the First Telehealth Solution Powered by AI

November 20, 2020 — Densitas Inc., a global provider of A.I. technologies for digital mammography and breast screening...

Radiologists around the world will have access to a first-of-its-kind online breast density training tool designed to improve radiologists' ability to correctly identify women's breast density categories to comply with the Breast Imaging-Reporting and Data System (BI-RADS), thanks to a collaboration between DetectED-X and Volpara Health.

News | Breast Density | November 19, 2020

Volpara Health and DetectED-X Team Up to Improve Breast Density Assessment

November 19, 2020 — Radiologists around the world will have access to a first-of-its-kind online breast density...

Reduces the complexity of reporting for screening and diagnostic MRI eams to deliver time-saving and patient safety benefits

News | MRI Breast | November 18, 2020

Ikonopedia Releases Enhanced Breast MRI Reporting Module

November 18, 2020 — Ikonopedia announced the release of its newly updated next-generation breast MRI reporting module. ...

DensitasInc., a leading provider of A.I. technologies for digital mammography and breast screening, announced that NorthShore University HealthSystem (NorthShore), will deploy the densitas platform across its mammography facilities

News | Breast Imaging | November 16, 2020

NorthShore University HealthSystem Adopts Groundbreaking densitas intelliMammo Artificial Intelligence Platform for Precision Breast Cancer Screening

November 16, 2020 — Densitas Inc., a leading provider of A.I. technologies for digital mammography and breast screening...

An interview with Professor Christiane Kuhl, M.D., director of radiology, University Hospital Aachen, Germany, on the effects on breast imaging in the COVID-19 era

Getty Images

Feature | Breast Imaging | November 12, 2020 | By Dave Fornell

The Impact of COVID-19 on Breast Imaging

The pandemic forced many elective procedures, including most areas of cancer screening, to be put on hold to prioritize...

Images in a 55-year-old woman with a spiculated mass localized in the upper central quadrant (arrow in A, B, D, and E) of right breast detected with digital breast tomosynthesis (DBT) plus synthetic mammography (SM). Breast density was classified as category C with the Breast Imaging Reporting and Data System. Mass was invasive ductal carcinoma, stage I, and was estrogen and progesterone receptor positive and human epidermal growth factor receptor 2 negative. A, Image from SM in craniocaudal view. B, Single

Images in a 55-year-old woman with a spiculated mass localized in the upper central quadrant (arrow in A, B, D, and E) of right breast detected with digital breast tomosynthesis (DBT) plus synthetic mammography (SM). Breast density was classified as category C with the Breast Imaging Reporting and Data System. Mass was invasive ductal carcinoma, stage I, and was estrogen and progesterone receptor positive and human epidermal growth factor receptor 2 negative. A, Image from SM in craniocaudal view. B, Single-slice DBT image in craniocaudal view. C, Magnification of the lesion depicted in B. D, Image from SM in mediolateral oblique view. E, Single-slice DBT image in mediolateral oblique view. F, Magnification of the lesion depicted in E. Images courtesy of Radiological Society of North America

News | Breast Imaging | November 11, 2020

Tomosynthesis With Synthetic Mammography Improves Breast Cancer Detection

November 11, 2020 — Digital breast tomosynthesis (DBT), in combination with synthetic mammography, improves cancer...